
Survodutide
Dual GLP-1 and glucagon receptor agonist. Aggressive fat loss + energy expenditure boost.
What Survodutide is
Survodutide is a peptide designed to function as a dual agonist for both the glucagon-like peptide-1 (GLP-1) and glucagon receptors. By activating GLP-1 receptors, it is understood to reduce appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion, contributing to improved blood sugar regulation and feelings of fullness. Concurrently, its action on glucagon receptors is intended to increase energy expenditure and stimulate lipolysis, which is the breakdown of stored fats. This combined agonism aims to promote significant fat loss and improve various metabolic markers while mitigating the glucose-raising effects typically associated with glucagon activation alone. The peptide exhibits an extended pharmacokinetic profile, allowing for a prolonged presence in the system, which typically supports a once-weekly administration schedule in research protocols.
In research contexts, individuals investigating Survodutide for metabolic studies may observe initial impacts on satiety and appetite within the first few weeks, with more substantial alterations in body composition and metabolic parameters developing over several months of consistent use. Given its comprehensive dual mechanism, Survodutide is often studied as a primary agent in metabolic research, though its unique actions might also be explored in conjunction with other research compounds. Typical research cycles for evaluating sustained weight management and metabolic improvements often span 16 weeks or more. This peptide is for research purposes only and is not intended for human therapeutic use, and this information does not constitute medical advice.
Commonly reported effects
- Fat loss
- Increased metabolic rate
- Appetite suppression
Reported side effects & considerations
- Nausea
- GI distress
Storage & handling
LYOPHILIZED (unopened): store at 2-8°C (fridge) or -20°C (freezer) long-term. Protect from light.
AFTER RECONSTITUTION: refrigerate 2-8°C. Do NOT freeze. Discard after 30 days OR if the solution becomes cloudy, discolored, or contains particulates.
What people track
Because individual responses vary so much, the useful thing is your own record: what you logged and when, how much is left in the vial, and how your chosen metrics move over the weeks. Peptide Wizard keeps all of that in one place, alongside a 3D reference vial for Survodutide.
FAQ
What is Survodutide?
Dual GLP-1 and glucagon receptor agonist. Aggressive fat loss + energy expenditure boost.
What do people commonly report with Survodutide?
Commonly reported effects include fat loss, increased metabolic rate, appetite suppression.
How should Survodutide be stored?
LYOPHILIZED (unopened): store at 2-8°C (fridge) or -20°C (freezer) long-term. Protect from light.
How do I keep track of Survodutide in my research log?
Peptide Wizard lets you record each entry, keep a vial ledger so you know what's left, and chart your own metrics over time. It is a logbook and reference only — it does not calculate or recommend doses.
More in Metabolic / Weight Loss
CagrilintideLong-acting amylin analog. Suppresses appetite and slows gastric empty…
EloralintideSelective long-acting amylin receptor agonist (Lilly, LY3841136). Once…
RetatrutideTriple agonist (GLP-1, GIP, Glucagon). Investigational — most powerful…
SemaglutideGLP-1 receptor agonist. Reduces appetite, improves glucose control, an…
This page is educational. It does not contain dosing guidance and is not medical advice.